Corporate Board Profile
Tech Score: 67/100
6 mention(s) identify TODD C. PETERSON, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. | 2019-10-22 | Dr. Peterson has more than 30 years of experience in biotechnology and life sciences research and development across the areas of molecular biology, nucleic acids and genomics product and technology development. He served as Chief Technology Officer at Synthetic Genomics, Inc., a private company focused on synthetic biology and applied genomics technologies. He held research and development positions with increasing responsibilities at Genicon Sciences Corp., Trega Biosciences, Inc., Hybritech Inc. and Gen-Probe Incorporated, focusing on technology research, product development and commercialization. | Has extensive experience in biotechnology and life sciences research and development, including technology research and product development in genomics and synthetic biology, indicating technical skills relevant to software or programming. |
| Armata Pharmaceuticals, Inc. | 2020-10-22 | Dr. Peterson has served as Chief Technology Officer at Synthetic Genomics, Inc., a private company focused on synthetic biology and applied genomics technologies. He led Genomics and Synthetic Biology R&D at Invitrogen/Life Technologies. He obtained his M.A. in Biological Sciences and B.A. in Molecular Biology and Biochemistry. | He has over 30 years of experience in biotechnology and life sciences research and development, including technology research, product development, and commercialization in genomics and synthetic biology, indicating technical expertise likely including programming or related skills. |
| Armata Pharmaceuticals, Inc. | 2021-04-21 | Todd C. Peterson, Ph.D. has served as a member of the Board of Directors since October 2019. He has over 35 years of experience in biotechnology and life sciences research and development across molecular and cell biology, nucleic acids and genomics product and technology development. He was Chief Technology Officer at Synthetic Genomics, Inc., a leader in synthetic biology and applied genomics technologies. He obtained his Ph.D. in Microbiology at the University of Southern California School of Medicine and has a B.A. in Molecular Biology and Biochemistry. | Has extensive experience in biotechnology and life sciences research and development, including technology research, product development, and commercialization in genomics and synthetic biology, indicating technical expertise likely including programming or related skills. |
| Armata Pharmaceuticals, Inc. | 2022-10-17 | Dr. Peterson has over 35 years of experience in biotechnology and life sciences research and development across the areas of molecular and cell biology, nucleic acids and genomics product and technology development... He obtained his M.A. in Biological Sciences and B.A. in Molecular Biology and Biochemistry at the University of California, Santa Barbara. | Dr. Peterson has extensive experience in biotechnology and life sciences research and development, including genomics and synthetic biology technologies, and holds degrees in Microbiology and Biological Sciences, indicating strong technical and scientific expertise that likely includes programming skills. |
| Armata Pharmaceuticals, Inc. | 2023-08-03 | Dr. Peterson was Chief Technology Officer at Synthetic Genomics, Inc., a leader in synthetic biology and applied genomics technologies developing a robust portfolio of breakthrough solutions addressing major global issues. | Dr. Peterson has a Ph.D. in Microbiology and extensive experience in biotechnology and life sciences research and development, including technology strategy and growth initiatives, indicating adjacent technical expertise though not explicitly programming. |
| Armata Pharmaceuticals, Inc. | 2024-04-29 | Dr. Peterson was a postdoctoral fellow at the Max Planck Institute in Cologne, Germany after receiving his Ph.D. in Microbiology at the University of Southern California School of Medicine. He has over 35 years of experience in biotechnology and life sciences research and development across molecular and cell biology, nucleic acids and genomics product and technology development. | Dr. Peterson has a Ph.D. in Microbiology and extensive experience in biotechnology, genomics, and synthetic biology, including technology development, indicating relevant technical skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-10-22 | Dr. Peterson has more than 30 years of experience in biotechnology and life sciences research and development across the areas of molecular biology, nucleic acids and genomics product and technology development. He served as Chief Technology Officer at Synthetic Genomics, Inc., a private company focused on synthetic biology and applied genomics technologies. He held research and development positions with increasing responsibilities at Genicon Sciences Corp., Trega Biosciences, Inc., Hybritech Inc. and Gen-Probe Incorporated, focusing on technology research, product development and commercialization. |
| 2020-03-06 | Todd C. Peterson, Ph.D. (Director) |
| 2020-10-22 | Dr. Peterson has served as Chief Technology Officer at Synthetic Genomics, Inc., a private company focused on synthetic biology and applied genomics technologies. He led Genomics and Synthetic Biology R&D at Invitrogen/Life Technologies. He obtained his M.A. in Biological Sciences and B.A. in Molecular Biology and Biochemistry. |
| 2021-02-26 | Todd C. Peterson, Ph.D. (Director) |
| 2021-04-21 | Todd C. Peterson, Ph.D. has served as a member of the Board of Directors since October 2019. He has over 35 years of experience in biotechnology and life sciences research and development across molecular and cell biology, nucleic acids and genomics product and technology development. He was Chief Technology Officer at Synthetic Genomics, Inc., a leader in synthetic biology and applied genomics technologies. He obtained his Ph.D. in Microbiology at the University of Southern California School of Medicine and has a B.A. in Molecular Biology and Biochemistry. |
| 2022-03-09 | Dr. Peterson is a director with a Ph.D., no software-related skills mentioned. |
| 2022-10-17 | Dr. Peterson has over 35 years of experience in biotechnology and life sciences research and development across the areas of molecular and cell biology, nucleic acids and genomics product and technology development... He obtained his M.A. in Biological Sciences and B.A. in Molecular Biology and Biochemistry at the University of California, Santa Barbara. |
| 2023-08-03 | Dr. Peterson was Chief Technology Officer at Synthetic Genomics, Inc., a leader in synthetic biology and applied genomics technologies developing a robust portfolio of breakthrough solutions addressing major global issues. |
| 2024-04-29 | Dr. Peterson was a postdoctoral fellow at the Max Planck Institute in Cologne, Germany after receiving his Ph.D. in Microbiology at the University of Southern California School of Medicine. He has over 35 years of experience in biotechnology and life sciences research and development across molecular and cell biology, nucleic acids and genomics product and technology development. |
Data sourced from SEC filings. Last updated: 2025-10-11